Trevena, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Pipeline
    • Overview
    • TRV250
    • TRV734
    • TRV045
    • TRV027
  • Products
    • OLINVYKâ„¢ (oliceridine) injection
  • Medical Affairs
    • Investigator-Initiated Trials
    • Contact Medical Information
  • Publications
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial Info
    • Stock Info
    • Resources
    • Governance
  • Careers
  • Contact
    • Contact Medical Information
    • Whistleblower Hotline

Press Releases

Investors

Investors

  • Overview
  • Press Releases
  • Events & Presentations
    • Presentations
    • IR Calendar
  • Financial Info
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Stock Info
    • Quote
    • Analyst Coverage
  • Resources
    • Email Alerts
    • Contacts
    • FAQ
  • Governance
    • Overview
    • Management Team
    • Board of Directors
    • Governance Documents

Trevena to Present at the Needham & Company 15th Annual Healthcare Conference

Apr 07, 2016 7:00am EDT

Trevena Announces Presentations at the 41st Annual Regional Anesthesiology and Acute Pain Medicine Meeting

Mar 31, 2016 7:00am EDT

Trevena Reports Full Year 2015 Financial Results

Mar 09, 2016 7:00am EST

Trevena to Present at Three Upcoming Investor Events in March

Mar 03, 2016 7:00am EST

Trevena to Host Conference Call on March 9th to Discuss Full Year 2015 Financial Results

Mar 02, 2016 4:01pm EST

Trevena, Inc. Receives FDA Breakthrough Therapy Designation for Oliceridine for the Management of Moderate-to-Severe Acute Pain

Feb 22, 2016 7:00am EST

Trevena to present at the 2016 RBC Capital Markets' Global Healthcare Conference

Feb 17, 2016 7:00am EST

Trevena to present at the 18th Annual BIO CEO & Investor Conference

Feb 03, 2016 4:01pm EST

Trevena, Inc. Announces Initiation of Oliceridine Phase 3 Clinical Program With Multi-Procedure Safety and Tolerability Study

Jan 19, 2016 7:00am EST

Trevena, Inc. added to NASDAQ Biotechnology Index (NBI)

Dec 16, 2015 7:00am EST
RSS
  • Prev
    • 1...
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • ...26
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
    © 2021 Trevena, Inc. All Rights Reserved.
    Privacy Policy Terms of Use Disclaimer Sitemap